Nanoform Finland Oyj (STO:NANOFS)
8.82
-0.20 (-2.22%)
At close: Feb 9, 2026
Nanoform Finland Oyj Employees
Nanoform Finland Oyj had 173 employees as of September 30, 2025. The number of employees decreased by 4 or -2.26% compared to the same quarter last year.
Employees
173
Change
-4
Growth
-2.26%
Revenue / Employee
245.42K SEK
Profits / Employee
-1.39M SEK
Market Cap
750.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 173 | -4 | -2.26% |
| Jun 30, 2025 | 175 | 1 | 0.57% |
| Mar 31, 2025 | 179 | 13 | 7.83% |
| Dec 31, 2024 | 181 | 16 | 9.70% |
| Sep 30, 2024 | 177 | 12 | 7.27% |
| Jun 30, 2024 | 174 | 16 | 10.13% |
| Mar 31, 2024 | 166 | 14 | 9.21% |
| Dec 31, 2023 | 165 | 15 | 10.00% |
| Sep 30, 2023 | 165 | 22 | 15.38% |
| Jun 30, 2023 | 158 | 15 | 10.49% |
| Mar 31, 2023 | 152 | 22 | 16.92% |
| Dec 31, 2022 | 150 | 25 | 20.00% |
| Sep 30, 2022 | 143 | 27 | 23.28% |
| Jun 30, 2022 | 143 | 37 | 34.91% |
| Mar 31, 2022 | 130 | 43 | 49.43% |
| Dec 31, 2021 | 125 | 51 | 68.92% |
| Sep 30, 2021 | 116 | 48 | 70.59% |
| Jun 30, 2021 | 106 | 51 | 92.73% |
| Mar 31, 2021 | 87 | 37 | 74.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 124 |
| Oncopeptides AB | 75 |
| Genovis AB (publ.) | 36 |
| Xspray Pharma AB | 26 |
| Cantargia AB | 23 |
| Corline Biomedical AB | 13 |
| Ascelia Pharma AB | 11 |
| Medivir AB | 10 |